Journal for ImmunoTherapy of Cancer (Nov 2023)

495 INB03: a new immune checkpoint inhibitor that reprograms polarization and promotes ADCP in human macrophages

Sofia Bruni,
Maria F Mercogliano,
Roxana Schillaci

Affiliations

Sofia Bruni: Laboratorio de Mecanismos Moleculares de Carcinogénesis, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina
Maria F Mercogliano: Laboratorio de Mecanismos Moleculares de Carcinogénesis, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina
Roxana Schillaci: Laboratorio de Mecanismos Moleculares de Carcinogénesis, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0495
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal